Novel Antisense-Peptide Nucleic Acids to Prevent Bacterial Biofilm Among Gram-Negative Bacteria Implicated in Catheter-Associated Urinary Tract Infections
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Biofilms develop in sequential steps resulting in the formation of three-dimensional communities of microorganisms that are encased in self-produced extracellular polymeric substances. Biofilms play a key role in device-associated infections, such as catheter-associated urinary tract infections (CAUTIs), because they protect microorganisms from standard antimicrobial therapies. Current strategies to prevent biofilm formation in catheter-related infections, including prophylactic antibiotics and antibiotic-coated catheters, have been unsuccessful, highlighting a need for novel technologies. In this study, biofilm-forming phenotypes of common Gram-negative bacteria associated with CAUTIs were treated with antisense-peptide nucleic acids (PNAs) and biofilm biomass and bacterial viability were quantified after 24 or 48 hours of treatment. A cocktail of PNAs targeting the global regulator genes rsmA , amrZ , and rpoS in Pseudomonas aeruginosa significantly reduced biofilm biomass and viability. Antisense-wide-range PNAs against these same gene targets and the motility regulator gene motA inhibited biofilm formation among isolates of Klebsiella pneumoniae , Enterobacter cloacae , Escherichia coli , and Proteus mirabilis , but did not reduce bacterial viability. These results suggest that antisense-PNAs are a promising new technology in preventing biofilm formation in urinary catheters, especially as a potential complement to conventional antimicrobials.